Dr. med.  

Sven Wegner


Presentations

Ustekinumab improves patient-reported outcomes, including DLQI and psoriasis symptoms and signs in a German real-life setting: one year-results from the PERSIST study 09 October 2019 00:00 - 00:00
Ustekinumab is effective on region-specific psoriasis in a real world setting: one-year results from the PERSIST study 09 October 2019 00:00 - 00:00

Abstracts

Ustekinumab improves patient-reported outcomes, including DLQI and psoriasis symptoms and signs in a German real-life setting: one year-results from the PERSIST study Psoriasis More
Ustekinumab is effective on region-specific psoriasis in a real world setting: one-year results from the PERSIST study Psoriasis More